Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma by unknow

Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma by unknow

Author:unknow
Format: pdf
Tags: multiple myeloma, HDAC inhibitor, bisthianostat, pharmacodynamics, pharmacokinetics, phase 1a clinical trial, antitumor drug
Publisher: Springer US
Published: 2022-03-10T09:54:20+00:00


Download



Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.